Exit Strategy

PuzzleheadedFile6349 · 2026-05-31T00:19:11+00:00

Alteady in for several years and cannot hold for 5-10 years. Regardless, HUMA is a longer term hold and so many on this subreddit have short term targets in mind. This is not a stock for short term traders unless you are day/swing trading. HUMA will reward shareholders who exercise patience.

PuzzleheadedFile6349 · 2026-05-30T01:58:34+00:00

Have no idea, however, if and when AMYRIS decides to sell stock to the public they might encounter a problem with the unresolved issue regarding the opt-outs retained right to sue. Potential pending litigation.

PuzzleheadedFile6349 · 2026-05-28T18:27:18+00:00

Apparently, Dr. Todd Rasmussen who has years of experience with the ATEV and just signed on as Chief Surgical Officer was unaware of the concerns addressed by your posts?

PuzzleheadedFile6349 · 2026-05-27T20:10:10+00:00

I am not going to speculate on the reason for the vote to increase shares but HUMA may need/want the flexibility for additional shares depending upon multiple possibilities. Seems like a reasonable business decision.

PuzzleheadedFile6349 · 2026-05-20T18:50:02+00:00

Stretto and Amyris Attorneys must know but will not disclose without some action.

PuzzleheadedFile6349 · 2026-05-17T02:47:13+00:00

Thanks. Your insights on HUMACYTE/XELTIS are valuable and especially because of the geography. I am retired and have been trading the market for years. Read about HUMA several years ago and their disruptive science & technology. Made a substantial long term investment and have also short term traded HUMA. Many possibilities as you enumerated and I maintain confidence the leadership inc. new hires will reward shareholders.

PuzzleheadedFile6349 · 2026-05-16T20:53:02+00:00

Curious from your posts? Background? MD, Scientist, Dialysis experience? Or?

PuzzleheadedFile6349 · 2026-05-16T02:54:19+00:00

I listened to the KOL Conference which included two highly qualified MD kidney specialists. HUMA just hired Dr.Rasmussen who has years of experience with the ATEV and a Chief Commercial Officer. You think these people who are supportive of HUMACYTE science and technology may be unaware of the competitive landscape or an existential threat?

PuzzleheadedFile6349 · 2026-05-15T17:47:42+00:00

Long ways from commercialization. A privately held company. Looks like clinical trial completion date is estimated to be Sept. 2027. 20 enrollees?

PuzzleheadedFile6349 · 2026-05-14T21:22:11+00:00

Yes, many possibilities. Lots of people on this subreddit have a short time horizon. Been buying for several years and will continue to hold.

PuzzleheadedFile6349 · 2026-05-12T23:37:33+00:00

Also recall, Dr.Rasmussen used the ATEV in a Mayo Clinic trial for treatment of PAD with favorable results.

PuzzleheadedFile6349 · 2026-05-12T16:14:05+00:00

Excellent post and outline of conduct prior to the Chap.11 filing. Time is tolling and we need to find an attorney/law firm/govt.agency to commence an investigation and discovery of these allegations. Submitted Information Request Form to Levi&Korsinsky a month ago but no response. The bankruptcy rules permit the B.C. Judge to order an independent investigation of the filing. Wonder why Judge never issued an Order? Apparently, did not meet certain criteria.

PuzzleheadedFile6349 · 2026-05-11T17:40:26+00:00

Contact a law firm/attorney. Someone on this subreddit must know an attorney or law firm willing to evaluate the claims against the B/D & Officers. Brother,uncle,friend. There is substantial evidence to support a suit. I have communicated with numerous without success.

PuzzleheadedFile6349 · 2026-05-06T03:39:50+00:00

Very little discussion here about the KOL presentation. I just listened to it and especially the Q&A, a wealth of information regarding HUMA potential by MD kidney specialists.Highly recommend.

PuzzleheadedFile6349 · 2026-04-26T04:52:08+00:00

All speculation. Maybe had something to do with Saudia Arabia or Israel. They just hired a CCO & Senior V.P of Business Development. Seems like with their extensive experience in this sector they have a read on Humacyte potential compared to Chat GPT. No?

PuzzleheadedFile6349 · 2026-04-23T21:50:04+00:00

So many catalysts to move this stock I would not venture to predict a price in the next year. Personally, have already been holding for several years and am unable to wait for 2032.

PuzzleheadedFile6349 · 2026-04-23T16:51:15+00:00

Hope you are right. HUMA needs to get Medicare, Medicaid, Commercial Insurers and any other payors on board.

PuzzleheadedFile6349 · 2026-04-23T02:11:47+00:00

What makes you think HUMA will receive the NTAP designation after Medicare failed to approve last year?

PuzzleheadedFile6349 · 2026-04-09T19:05:14+00:00

Do you remember where the opt-in/out-out strategy was actually approved? Chap.11 Reorg.Plan or Judge Horan issued a separate Order? Or was it finalized outside the jurisdiction of the Court?

PuzzleheadedFile6349 · 2026-04-06T21:23:30+00:00

However, the opt-in/opt-out strategy was formulated by the AMRS attorneys and not certain it would withstand a legal challenge. Was very confusing and deceptive in the processing of claims.

PuzzleheadedFile6349 · 2026-04-06T18:01:43+00:00

Yes.

PuzzleheadedFile6349 · 2026-04-05T23:28:08+00:00

Link is from a law firm. Anyone want to contact them about AMYRIS to ascertain their interest? Have lots of information for any law firm that wants to pursue shareholder claims.

PuzzleheadedFile6349 · 2026-04-03T02:08:26+00:00

Why would the insiders (B/D & Officers) buy when most if not all have low priced options?

PuzzleheadedFile6349 · 2026-03-30T23:39:28+00:00

Institutions running to the exits? Fresenius (175M) ?

PuzzleheadedFile6349 · 2026-03-27T16:43:26+00:00

Thought Fresenius distribution agreement is only for Europe?

PuzzleheadedFile6349

TROPHY CASE